Skip to content

Royan Institute

  Home arrow News arrow International News arrow International News arrow Vitrolife AB (publ): EmbryoGlue(R) Increases The Chances Of The Infertile Having Children
Vitrolife AB (publ): EmbryoGlue(R) Increases The Chances Of The Infertile Having Children PDF Print E-mail
A study which shows that significantly more (63%) patients had children when EmbryoGlue® was used, compared with the control group, was presented at the ongoing ESHRE conference in Stockholm. Vitrolife's patented medium EmbryoGlue® is used when reintroducing embryos in connection with assisted fertilization.
 
 

Main Menu